InsidersTradesSigma
Follow the TenNor Therapeutics (Suzhou) Ltd. - B - H Shares stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Market capitalisation: €11.4bn. The latest transaction was filed on 8 June 2026 (Other). Among the most active insiders: MA ZHENKUN. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
TenNor Therapeutics (Suzhou) Ltd. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It specializes in the research and commercialization of targeted therapies.